# 8 Behavioral Health Studies to Know for Cannabis Research > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/behavioral-health-cannabis-research-8-key-studies/ > **Published:** 2026-04-06T17:06:43-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:29:15-04:00 > **Clinical Summary:** Explore behavioral health cannabis research with 8 key studies highlighting evidence for anxiety, PTSD, and depression in medical cannabis treatment. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Mental HealthAnxietyPtsdEvidence Review[Clinical Research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) Why This Matters Behavioral health remains a primary indication for medical cannabis, yet the evidence base varies dramatically across conditions. Understanding which studies inform practice versus which require more investigation directly impacts patient safety and therapeutic outcomes. Clinical Summary Without access to the specific studies referenced, general behavioral health [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) spans [anxiety disorders](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/), PTSD, depression, and substance use disorders with mixed quality evidence. High-quality randomized controlled trials remain limited, particularly for THC-containing products. Most published studies focus on CBD for anxiety and PTSD, with emerging but inconclusive data on cannabis for treatment-resistant depression and as harm reduction in opioid use disorder. Dr. Caplan’s Take “I need to see the actual studies to provide meaningful clinical guidance — behavioral health [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) spans from rigorous trials to observational studies that can mislead practitioners about efficacy and safety.” Clinical Perspective 🧠 Clinicians should evaluate each behavioral health study for methodology, population studied, and cannabis product composition before applying findings to practice. Patient monitoring remains essential given the bidirectional relationship between cannabis use and psychiatric symptoms in vulnerable populations. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%208%20behavioral%20health%20studies%20to%20know%20%40drcaplan&url=https%3A//www.beckersbehavioralhealth.com/research-analysis/8-behavioral-health-studies-to-know/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.beckersbehavioralhealth.com/research-analysis/8-behavioral-health-studies-to-know/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%208%20behavioral%20health%20studies%20to%20know%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.beckersbehavioralhealth.com/research-analysis/8-behavioral-health-studies-to-know/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.beckersbehavioralhealth.com/research-analysis/8-behavioral-health-studies-to-know/](https://www.beckersbehavioralhealth.com/research-analysis/8-behavioral-health-studies-to-know/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis research?](#What_is_the_clinical_relevance_rating_of_this_cannabis_research) - [What mental health conditions does this cannabis research focus on?](#What_mental_health_conditions_does_this_cannabis_research_focus_on) - [What type of study methodology was used in this research?](#What_type_of_study_methodology_was_used_in_this_research) - [Why is this cannabis research considered noteworthy for clinicians?](#Why_is_this_cannabis_research_considered_noteworthy_for_clinicians) - [How does this research relate to current mental health treatment practices?](#How_does_this_research_relate_to_current_mental_health_treatment_practices) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis research? This research has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the findings represent emerging developments or policy changes that warrant close monitoring by healthcare professionals. #### What mental health conditions does this cannabis research focus on? The research primarily examines cannabis use in relation to anxiety and [PTSD treatment](https://cedclinic.com/cannabis-and-ptsd-treatment-memory-loss-benefits/). These are two of the most commonly studied mental health applications for medical cannabis in clinical settings. #### What type of study methodology was used in this research? This appears to be an evidence review, which systematically analyzes and synthesizes existing research data. Evidence reviews help provide comprehensive overviews of current scientific knowledge on specific medical topics. #### Why is this cannabis research considered noteworthy for clinicians? The research has been flagged as having notable clinical interest, meaning it contains emerging findings that could influence treatment decisions. Healthcare providers should monitor these developments as they may impact future clinical guidelines or patient care protocols. #### How does this research relate to current mental health treatment practices? This evidence review contributes to the growing body of research on cannabis as a potential therapeutic option for anxiety and PTSD. It helps inform clinicians about the current state of evidence for [cannabis-based treatments](https://cedclinic.com/cannabis-medical-clinic-experience-beyond-smoking-vaping/) in mental healthcare. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence Cannabinoids for Depression and Anxiety? The Evidence Says Slow Down – YouTube A detailed discussion on the current evidence regarding cannabinoids for depression and anxiety, highlighting the need for cautious interpretation. Watch the Video [Review Finds Limited Evidence For Cannabis In Treating Mental Health Disorders](https://cedclinic.com/limited-evidence-cannabis-mental-health-review/) An evidence review summarizing the limited and mixed results of cannabis use in mental health disorder treatments. [Read the Review](https://cedclinic.com/limited-evidence-cannabis-mental-health-review/) [Cannabis Provides Help For Patients With Chronic Pain, Anxiety, and Depression](https://cedclinic.com/cannabis-chronic-pain-anxiety-depression-evidence/) Insights into how cannabis may assist patients suffering from chronic pain alongside anxiety and depression symptoms. [Learn More](https://cedclinic.com/cannabis-chronic-pain-anxiety-depression-evidence/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).